Intentionality in adherence to long-term therapies. Results from an online survey of 3,001 patients with cardio-metabolic pathologies in France

References

• WHO Report. Adherence to Long-Term Therapies, Evidence for Action. Eduardo SE, ed. World Health Organization; 2003.
   Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
   PubMed Web of Science ®Google Scholar
• Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437–443. doi:10.1592/phco.28.4.437
   PubMed Web of Science ®Google Scholar
• Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current situation of medication adherence in hypertension. Front Pharmacol. 2017;8:100. doi:10.3389/fphar.2017.00100
   PubMed Web of Science ®Google Scholar
• Peacock E, Krousel-Wood M. Adherence to antihypertensive therapy. Med Clin North Am. 2017;101(1):229–245. doi:10.1016/j.mcna.2016.08.005
   PubMed Web of Science ®Google Scholar
• George M. Adherence in asthma and COPD: new strategies for an old problem. Respir Care. 2018;63(6):818–831. doi:10.4187/respcare.05905
   PubMed Web of Science ®Google Scholar
• Claros MP, Messa CVM, García-Perdomo HA. Adherence to oral pharmacological treatment in cancer patients: systematic review. Oncol Rev. 2019;13(1):402. doi:10.4081/oncol.2019.402
   Web of Science ®Google Scholar
• Fatoye F, Smith P, Gebrye T, Yeowell G. Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open. 2019;9(4):e027049. doi:10.1136/bmjopen-2018-027049
   PubMed Web of Science ®Google Scholar
• Curtis SE, Boye KS, Lage MJ, Garcia-Perez LE. Medication adherence and improved outcomes among patients with type 2 diabetes. Am J Manag Care. 2017;23(7):e208–e214. PMID: 28850793.
   Google Scholar
• Khunti K, Seidu S, Kunutsor S, Davies M. Association between adherence to pharmacotherapy and outcomes in type 2 diabetes: a meta-analysis. Diabetes Care. 2017;40(11):1588–1596. doi:10.2337/dc16-1925
   PubMed Web of Science ®Google Scholar
• Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication non-adherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836–1841.
   PubMed Web of Science ®Google Scholar
• Mennini FS, Marcellusi A, von der Schulenburg JM, et al. Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur J Health Econ. 2015;16(1):65–72. doi:10.1007/s10198-013-0554-4
   PubMed Web of Science ®Google Scholar
• Giugliano D, Maiorino MI, Bellastella G, Esposito K. Glycemic control in type 2 diabetes: from medication non-adherence to residual vascular risk. Endocrine. 2018;61(1):23–27. PMID: 29322300. doi:10.1007/s12020-017-1517-9
   Web of Science ®Google Scholar
• Burnier M, Egan BM. Adherence in hypertension. Circ Res. 2019;124(7):1124–1140. PMID: 30920917. doi:10.1161/CIRCRESAHA.118.313220
   PubMed Web of Science ®Google Scholar
• Liberopoulos EN, Florentin M, Mikhailidis DP, Elisaf MS. Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opin Drug Saf. 2008;7(6):717–725. PMID: 18983218. doi:10.1517/14740330802396984
   PubMed Web of Science ®Google Scholar
• Leslie KH, McCowan C, Pell JP. Adherence to cardiovascular medication: a review of systematic reviews. J Public Health. 2019;41(1):e84–e94. doi:10.1093/pubmed/fdy088
   Web of Science ®Google Scholar
• Chan AHY, Cooper V, Lycett H, Horne R. Practical barriers to medication adherence: what do current self- or observer-reported instruments assess? Front Pharmacol. 2020;11:572. doi:10.3389/fphar.2020.00572
   PubMed Web of Science ®Google Scholar
• Gast A, Mathes T. Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst Rev. 2019;8(1):112. PMID: 31077247; PMCID: PMC6511120. doi:10.1186/s13643-019-1014-8
   PubMed Web of Science ®Google Scholar
• Genberg BL, Lee Y, Rogers WH, Wilson IB. Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time. AIDS Behav. 2015;19(1):85–92. doi:10.1007/s10461-014-0775-2
   PubMed Web of Science ®Google Scholar
• Shubber Z, Mills EJ, Nachega JB, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and meta-analysis. PLoS Med. 2016;13(11):e1002183. doi:10.1371/journal.pmed.1002183
   PubMed Web of Science ®Google Scholar
• Sinnott SJ, Buckley C, O’Riordan D, Bradley C, Whelton H. The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations: a systematic review and meta-analysis. PLoS One. 2013;8(5):e64914. doi:10.1371/journal.pone.0064914
   PubMed Web of Science ®Google Scholar
• Peh KQE, Kwan YH, Goh H, et al. An adaptable framework for factors contributing to medication adherence: results from a systematic review of 102 conceptual frameworks. J Gen Intern Med. 2021:1–2. PMID: 33660211. doi:10.1007/s11606-021-06648-1.
   Web of Science ®Google Scholar
• Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. A discussion paper. Int J Nurs Stud. 2007;44(8):1468–1477. doi:10.1016/j.ijnurstu.2006.07.010
   PubMed Web of Science ®Google Scholar
• Thorneloe RJ, Griffiths CEM, Emsley R, Ashcroft DM, Cordingley L. British association of dermatologists biologic interventions register, psoriasis stratification to optimise relevant therapy study groups. Intentional and unintentional medication non-adherence in psoriasis: the role of patients’ medication beliefs and habit strength. J Invest Dermatol. 2018;138:785–794.
   PubMed Web of Science ®Google Scholar
• Molloy GJ, Messerli-Bürgy N, Hutton G, Wikman A, Perkins-Porras L, Steptoe A. Intentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study. J Psychosom Res. 2014;76(5):430–432. doi:10.1016/j.jpsychores.2014.02.007
   PubMed Web of Science ®Google Scholar
• Lindquist LA, Go L, Fleisher J, Jain N, Friesema E, Baker DW. Relationship of health literacy to intentional and unintentional non-adherence of hospital discharge medications. J Gen Intern Med. 2012;27(2):173–178. doi:10.1007/s11606-011-1886-3
   PubMed Web of Science ®Google Scholar
• Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res. 2012;12(1):98–109. doi:10.1186/1472-6963-12-98
   PubMed Web of Science ®Google Scholar
• Triandis HC. Values, attitudes and interpersonal behavior. Nebr Symp Motiv. 1980;27:195–259.
   PubMedGoogle Scholar
• Phillips LA, Cohen J, Burns E, Abrams J, Renninger S. Self-management of chronic illness: the role of ‘habit’ versus reflective factors in exercise and medication adherence. J Behav Med. 2016;39(6):1076–1091. doi:10.1007/s10865-016-9732-z
   PubMed Web of Science ®Google Scholar
• Reach G, Pellan M, Crine A, Touboul C, Ciocca A, Djoudi Y. Holistic psychosocial determinants of adherence to medication in people with type 2 diabetes. Diabetes Metab. 2018;44(6):500–507. doi:10.1016/j.diabet.2018.06.001
   PubMed Web of Science ®Google Scholar
• Reach G. The role of habit in therapeutic adherence. Diabet Med. 2005;22(4):415–420. doi:10.1111/j.1464-5491.2004.01449.x
   Web of Science ®Google Scholar
• Searle J. Intentionality: An Essay in the Philosophy of Mind. New York: Cambridge University Press; 1983.
   Google Scholar
• Kahneman D. Thinking, Fast and Slow. Farrar, Straus & Giroux; 2011.
   Google Scholar
• Reach G. The Mental Mechanisms of Patient Adherence to Long Term Therapies, Mind and Care. Foreword by Pascal Engel. Springer; 2015.
   Google Scholar
• Norstat Panel Privacy Policy. Available from: https://www.norstatpanel.com/en/privacy-policy. Accessed July 14, 2021.
   Google Scholar
• Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Evaluation de l’observance du traitement anti-hypertenseur par un questionnaire: mise au point et utilisation dans un service spécialisé. Presse Med. 2001;30:1044–1048.37.
   PubMed Web of Science ®Google Scholar
• Ratanawongsa N, Karter AJ, Parker MM, et al. Communication and medication adherence: the Diabetes Study of Northern California. JAMA Intern Med. 2013;173(3):210–218. doi:10.1001/jamainternmed.2013.1216
   PubMed Web of Science ®Google Scholar
• Esomar Guideline for Online Research. Available from: https://www.esomar.org/uploads/public/knowledge-and-standards/codes-and-guidelines/ESOMAR_Guideline-for-online-research.pdf. Accessed March 15, 2021.
   Google Scholar
• Kawalec P, Holko P, Gawin M, Pilc A. Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis. Arch Med Sci. 2018;14(5):1125–1136. doi:10.5114/aoms.2018.77561
   PubMed Web of Science ®Google Scholar
• Moon J, Cohen Sedgh R, Jackevicius CA. Examining the nocebo effect of statins through statin adverse events reported in the food and drug administration adverse event reporting system. Circ Cardiovasc Qual Outcomes. 2021;14(1):e007480. PMID: 33161769. doi:10.1161/CIRCOUTCOMES.120.007480
   PubMed Web of Science ®Google Scholar
• Thom DH. Stanford trust study physicians. physician behaviors that predict patient trust. J Fam Pract. 2001;50:323–328.
   PubMed Web of Science ®Google Scholar
• Glasgow RE, Emont S, Miller DC. Assessing delivery of the five “As” for patient-centered counseling. Health Promot Int. 2006;21(3):245–255. doi:10.1093/heapro/dal017
   PubMed Web of Science ®Google Scholar
• Safran DG, Taira DA, Rogers WH, Kosinski M, Ware JE, Tarlov AR. Linking primary care performance to outcomes of care. J Fam Pract. 1998;47:213–220.
   PubMed Web of Science ®Google Scholar
• Bonds DE, Camacho F, Bell RA, Duren-Winfield VT, Anderson RT, Goff DC. The association of patient trust and self-care among patients with diabetes mellitus. BMC Fam Pract. 2004;5(1):26. doi:10.1186/1471-2296-5-26
   PubMedGoogle Scholar
• Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(8):1233–1239. doi:10.1002/ibd.20883
   PubMed Web of Science ®Google Scholar
• Zikmund-Fisher BJ, Hofer TP, Klamerus ML, Kerr EA. First things first: difficulty with current medications is associated with patient willingness to add new ones. Patient. 2009;2(4):221–231. doi:10.2165/11313850-000000000-00000
   PubMedGoogle Scholar
• Lee R, Taira DA. Adherence to oral hypoglycemic agents in Hawaii. Prev Chronic Dis. 2005;2:A09.
   Google Scholar
• Reach G. Temporality in chronic diseases and adherence to long-term therapies: from philosophy to science and back. Diabetes Metab. 2019;45(5):419–428. doi:10.1016/j.diabet.2018.11.002
   PubMed Web of Science ®Google Scholar
• Bailey PE, Leon T. A systematic review and meta-analysis of age-related differences in trust. Psychol Aging. 2019;34(5):674–685. doi:10.1037/pag0000368
   PubMed Web of Science ®Google Scholar
• Zhao DH, Rao KQ, Zhang ZR. Patient trust in physicians: empirical evidence from Shanghai, China. Chin Med J. 2016;129(7):814–818. doi:10.4103/0366-6999.178971
   PubMed Web of Science ®Google Scholar
• Park Y, Park YH, Park KS. Determinants of non-adherences to long-term medical therapy after myocardial infarction: a cross-sectional study. Int J Environ Res Public Health. 2020;17(10):3585. doi:10.3390/ijerph17103585
   Web of Science ®Google Scholar
• Iihara N, Nishio T, Okura M, et al. Comparing patient dissatisfaction and rational judgment in intentional medication non-adherence versus unintentional nonadherence. J Clin Pharm Ther. 2014;39(1):45–52. doi:10.1111/jcpt.12100
   PubMed Web of Science ®Google Scholar
• Johnson RJ. Finding the truth: multivariable analysis and the assassination of Abraham Lincoln. J R Coll Phys Edinb. 2018;48(2):153–154. doi:10.4997/JRCPE.2018.210
   Web of Science ®Google Scholar
• Reach G. Obedience and motivation as mechanisms for adherence to medication. A study in obese type 2 diabetic patients. Patient Prefer Adherence. 2011;5:523–531. doi:10.2147/PPA.S24518
   Web of Science ®Google Scholar
• Reach G, Chenuc G, Maigret P, Elias-Billon I, Martinez L, Flipo RM. Implication of character traits In adherence to treatment in people with gout: a reason for considering non-adherence as a syndrome. Patient Prefer Adherence. 2019;7(13):1913–1926. doi:10.2147/PPA.S227329
   Web of Science ®Google Scholar
• Bergkvist L, Rossiter JR. The predictive validity of multiple-Item versus single-item measures of the same constructs. J Mark Res. 2007;44(2):175–184. doi:10.1509/jmkr.44.2.175
   Web of Science ®Google Scholar
• Collins M, Shattell M, Thomas SP. Problematic interviewee behaviors in qualitative research. West J Nurs Res. 2005;27(2):188–199. doi:10.1177/0193945904268068
   PubMed Web of Science ®Google Scholar
• Hippocrates. Decorum, 14. In: Jones WHS, ed. Hippocrates Volume II. William Heinemann; 1923:267–302.
   Google Scholar
• Reach G. Decisions in the psychology of glucose monitoring. J Diabetes Sci Technol. 2019;13(6):1169–1174. doi:10.1177/193296819854109
   Google Scholar
• Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014:CD000011.
   PubMedGoogle Scholar